| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
7,623 |
6,563 |
$1.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,039 |
2,654 |
$28K |
| 3074F |
|
496 |
454 |
$24K |
| 3078F |
|
435 |
404 |
$21K |
| 3079F |
|
296 |
266 |
$18K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,910 |
1,719 |
$16K |
| 3077F |
|
250 |
238 |
$14K |
| 3075F |
|
187 |
174 |
$12K |
| 3080F |
|
178 |
173 |
$12K |
| 96127 |
|
305 |
248 |
$10K |
| 90658 |
|
105 |
103 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
106 |
104 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
28 |
$2K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
51 |
26 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
25 |
24 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
17 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
14 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
235 |
208 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
13 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17 |
14 |
$0.00 |